Biotech news
Americas
Natus Medical retaliates against startup’s complaint in a patent clash over wearable diagnostic and monitoring products for neurological conditions. 27 August 2025
Europe
The executive chair of Beck Greener enabled a smaller firm to swerve private equity and join its stable—a move that boosts what was already a "clear path to growth" under his bold leadership, discovers Sarah Speight. 26 August 2025
Americas
Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter “reasonable particularity” rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state. 13 August 2025
Americas
Firm takes over Novartis in major patent litigation | Move follows rival firm's withdrawal after conflict-of-interest challenge | Latham team led by new hire from Cravath. 13 August 2025
Americas
A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley. 12 August 2025
Americas
Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts. 11 August 2025
Careers
The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade. 11 August 2025
Americas
Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | BMS’s Indian patent covering the monoclonal antibody expires in May 2026. 21 July 2025
Americas
This LSPN session features experts from EIP, The Broad Institute of MIT and Harvard, Pfizer, and an independent specialist discussing the protection of life science innovations involving big data, AI, and machine learning. 21 July 2025
Americas
Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life sciences patents, as discussed at LSPN. 18 July 2025